Niki BioSolutions, Inc. Net Income (Loss) Attributable to Redeemable Noncontrolling Interest
Niki BioSolutions, Inc. (NIKI) reported Net Income (Loss) Attributable to Redeemable Noncontrolling Interest of -$1.73 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-04-28.
Discontinued › Income Statement
us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest · last filed 2023-04-28
| Period end | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 12 month |
|---|---|
| 2022-12-31 | -$1.73M 20-F · filed 2023-04-28 |
| 2021-12-31 | -$2.07M 20-F · filed 2023-04-28 |
| 2020-12-31 | -$2.15M 20-F · filed 2023-04-28 |
| 2019-12-31 | -$1.43M 20-F/A · filed 2023-01-17 |